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Aims. FDG-PET can be used to identify vulnerable plaques in atherosclerotic disease.
Clinical FDG-PET camera systems are restricted in terms of resolution for the visualization of
detailed inﬂammation patterns in smaller vascular structures. The aim of the study is to
evaluate the possible added value of a high-resolution microPET system in excised carotid
plaques using FDG.
Methods and Results. In this study, 17 patients with planned carotid endarterectomy were
included. Excised plaques were incubated in FDG and subsequently imaged with microPET.
Macrophage presence in plaques was evaluated semi-quantitatively by immunohistochemistry.
Plaque calciﬁcation was assessed additionally with CT and correlated to FDG uptake. Finally,
FDG uptake and macrophage inﬁltration were compared with patient symptomatology. Het-
erogeneous distributions and variable intensities of FDG uptake were found within the plaques.
A positive correlation between the distribution of macrophages and the FDG uptake (r 5 0.68,
P < .01) was found. A negative correlation was found between areas of calciﬁcations and FDG
uptake (r 52 0.84, P < .001). Ratio FDGmax values as well as degree of CD68 accumulation
were signiﬁcantly higher in CVA patients compared with TIA or amaurosis fugax patients
(P < .05) and CVA patients compared with asymptomatic patients (P < .05).
Conclusion. This ex vivo study demonstrates that excised carotid plaques can be visualized
in detail using FDG microPET. Enhancement of clinical PET/CT resolution for similar imaging
results in patients is needed. (J Nucl Cardiol 2011;18:1066–75.)
Key Words: Atherosclerosis Æ carotid artery Æ FDG Æ microPET Æ vulnerable plaque
INTRODUCTION
Rupture of carotid atherosclerotic plaques and sub-
sequent formation of thrombi or emboli are currently
recognized as the primary cause of acute cerebrovascular
disease.
1 The number of cerebrovascular events can be
reduced by surgical removal of the stenosed plaque in the
carotid artery. Currently, patients are selected for carotid
endarterectomy (CEA) based on symptomatology and
degree of stenosis.
2
Conventional imaging of luminal stenosis can be
used to identify plaque vulnerability, but lack of
standardized quantiﬁable duplex, magnetic resonance
imaging(MRI)/magneticresonanceangiography(MRA),
or radiographic criteria for plaque instability limit their
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1066reliability. Moreover, non-stenotic vulnerable plaques
may also be prone to rupture, whereas stenosing stable
lesions may remain stable and asymptomatic.
3 Plaque
biology rather than degree of stenosis determines the risk
of acute cerebrovascular events. Inﬂammation plays an
essential role in the pathophysiology of atherosclerosis.
4
Ahighprevalenceofmacrophage-richplaquesisfoundin
patient groups with acute cerebrovascular symptoms, and
markers of macrophage activation are more abundant in
ruptured plaques. In addition, macrophage inﬁltration is
one important cause of plaque instability.
5
Several studies have shown that [
18F]-ﬂuorodeoxy-
glucose (FDG) accumulates in plaques with high
macrophage density; however, this was performed on
clinical PET cameras with relative low resolution.
6-11
Therefore,FDGpositronemissiontomography/computed
tomography (PET/CT) has emerged as a non-invasive
imaging modality able to predict the susceptibility of
plaquestowardruptureonthepatients’grouplevel.FDG-
PET/(CT) studies have shown signiﬁcantly higher FDG
uptake in symptomatic plaques compared to asymptom-
atic plaques and healthy controls.
12-17 Despite these
promising results, it is hard to select high risk patients
based on FDG-PET/(CT) results, conceivably due to
limited clinical PET camera resolution and the lack of
validated clinical endpoint trials. Clinically, FDG uptake
in vulnerable plaques is difﬁcult to detect. The spatial
resolution of a clinical PET scanner ranges 5-10 mm and
smaller FDG avid atherosclerotic plaques will therefore
be missed. High-resolution microPET systems with a
spatial resolution of as low as 1 mm are able to visualize
smallermetabolicallyactivelesions.
18Furthermore,there
is evidence that FDG-uptake is correlated to the extent of
macrophage inﬁltration within a plaque using material
obtained from clinical patients.
19,20
The aim of this study is to evaluate whether
enhanced FDG uptake on high-resolution microPET
correlates with macrophage inﬁltration and, therefore,
with plaque instability and with neurological symptom
status. Also, the necessity for resolution enhancement in
currently available clinical PET/CT is evaluated.
METHODS
Patients
Twenty consecutive patients with signiﬁcant carotid
artery stenosis (70%-99%) who underwent CEA at the
Department of Surgery (Division of Vascular Surgery) in the
University Medical Center Groningen or the Martini Hospital
in Groningen participated in this study. The degree of stenosis
and basic morphologic features of the plaque were evaluated
by duplex ultrasound. Patient selection and operative technique
were based on the recommendations as published by NASCET
and ECST.
21,22 Out of twenty patients, three patients were
excluded from further analysis as their material was primarily
used for validation purposes in a pilot study. Of the remaining
seventeen patients, three patients had a conventional FDG-
PET/computed tomography angiography (CTA) 1 week before
CEA. Information about the clinical status was collected from
the hospital information system and included medical history,
diagnosis, treatment, medication, symptoms, smoking, and risk
factors.
Relevant baseline characteristics of the 17 patients are
summarized in Table 1. The median age was 71 years (range
45-82), 12 patients (71%) were male. The main risk factors
were lipid disorder in 9 (53%), hypertension in 12 (71%),
smoking in 10 (59%), and diabetes mellitus in 2 (12%)
patients. Eligibility for CEA was determined based on the
presence of a stenosis of 70%-99%, and in one patient (patient
2) with a degree of stenosis of 50%-70% due to ulcerative
plaque formation on ultrasound.
This study was approved by the Institutional Ethics
Review Boards of both hospitals and all included patients gave
written informed consent before inclusion in the study.
Plaque Preparation
CEA was performed under general anesthesia using
standard techniques; plaques were removed gently and trans-
ported in phosphate-buffered saline (PBS). The plaques were
then directly incubated in approximately 100 MBq FDG for
60 minutes by 37C. After incubation, resected plaques were
ﬂushed with PBS and were subsequently stored in a humid
environment during the microPET imaging procedure to pre-
vent dehydration. Immediately after the imaging procedure,
carotid plaque material was sliced transversely in 3-5 slides.
Careful attention was given to orientation and slice origin
(common carotid artery, bifurcation, and internal carotid
artery), and this was marked and noted. Then, the slices were
immediately ﬁxed in formalin for 48 hours and subsequently
embedded in parafﬁn.
Image Acquisition MicroPET/CT,
Reconstruction and Data Analysis
After incubation with FDG, 17 atherosclerotic plaques
were imaged using a microPET scanner (micro PET Focus
220, Siemens/Concorde). A list-mode protocol was used
(60 minutes). A transmission scan of 15 minutes with a
radioactive point source was obtained for the correction of
attenuation by tissue. Acquisition data were reconstructed
using iterative reconstruction and segmented attenuation. PET
image analyses were performed using standard software
(AsiPro VM 6.2.5.0; Siemens/Concorde and Siemens Inveon
Research Workplace (IRW) (Siemens Medical Systems,
Knoxville, Tennessee, USA).
Seven atherosclerotic plaques were also imaged using a
microCT scanner (Siemens Imtek MicroCAT II, Siemens
Medical Systems, Knoxville, Tennessee, USA). The CT sys-
tem was calibrated to acquire 512 projections at 55 kVp with a
57 9 85 mm
2 ﬁeld of view (FOV). The exposure time was
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FDG microPET and carotid plaques November/December 20111050 seconds and binning 4 (4 9 4 pixels = 1 pixel) was
used. After the microPET scanning was complete, the plaque
was turned axially and centered within the CT detector ring, to
maintain the same stereotactic position. Spatial resolution was
37 lm isotropic for CT and \1.3 mm at the center FOV for
PET imaging. The microPET and CT images were fused using
a software module in IRW. The plaque remained in the same
position on the bed for both PET and CT acquisitions and the
relative positions of the FOVs of the PET and CT were known.
A software module was used for fusion and co-registration of
PET and CT data, but if needed partly corrected manually.
Fused images were analyzed by placing volumes of interest
around the calciﬁed areas. PET images were analyzed and
categorized by one observer as follows: a region of interest
(ROI) was drawn around the whole plaque and mean FDG
uptake and maximum uptake were determined in MBq/mL and
corrected for background activity (lowest uptake region of the
remaining plaque). RatioFDGmax was calculated as maximum
FDG uptake (hot spot) divided by background activity. For
each section within the sliced plaque, the highest FDG uptake
value and the mean FDG uptake were determined by inserting
ROIs. RatioFDGoverall was calculated by dividing the mean
FDG uptake (whole slide) by the background activity. In
addition, the volume of calciﬁcation, as recognized as less
variable than the Agatston method,
23 within a plaque was
assessed by microCT and compared with maximum FDG
uptake of the corresponding plaque.
Reagents and Immunohistochemistry
FDG was produced at our institute according to the
Hamacher method (nucleophilic ﬂuorination reaction followed
by deprotection).
24 Sections (3 lm) of routinely processed,
formalin-ﬁxed, parafﬁn-embedded tissues were deparafﬁnized
and rehydrated. Endogenous peroxidase activity was blocked
using 0.3% H2O2 in PBS for 30 minutes at room temperature.
The sections were pre-treated with microwave antigen retrieval
methods using 0.01 M citric acid (pH 6.0) in distilled water.
Subsequently, nonspeciﬁc antigenic protein binding was
blocked with 4% normal goat serum in PBS for 20 minutes.
The degree of inﬂammation was evaluated by CD 68 immu-
nostaining for macrophages. Sections were incubated with
mouse anti-CD68 monoclonal antibody (clone KP1, Abcam,
Cambridge, UK) at a 1:100 dilution in PBS containing 1%
bovine serum albumin (BSA) for 2 hours at room temperature.
After washing, the sections were incubated with an Alexa-594
Figure 1. Clinical PET image with coronal (A), transverse (B), and sagittal (C) plane slices of a
patient showing FDG uptake in the affected right carotid artery (arrows). Coronal (D), transverse
(E), and sagittal plane (F) of corresponding lPET images of the same patient showing also patchy
FDG uptake and calciﬁed areas (white depositions).
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1%BSA) for 30 minutes at room temperature. 40,6-Diamidino-
2-phenylindole (DAPI, Molecular Probes, Eugene, Oregon,
USA) was added to this solution (1:2000) to visualize the
nuclei. Negative staining control sections received the same
treatment, except that the ﬁrst antibody was omitted. Sections
were washed with water and subsequently mounted in ﬂuo-
rescent-mounting medium (Dako, Glostrup, Denmark). Stained
sections were evaluated using ﬂuorescence microscopy (Leica
DM LB, Rijswijk, the Netherlands) with standard excitation
ﬁlters; DAPI, FITC, and TRITC.
The degree of inﬂammation in obtained histological
specimens was compared with the mean FDG values, corrected
for background FDG uptake in the corresponding ROI (ratio-
FDGoverall). The 17 obtained plaque specimens yielded 66
plaque sections (4 ± 1 sections/patient) after slicing.
Analysis of Immunohistochemical Staining
CD68 staining was analyzed and categorized indepen-
dently by two observers. Inter-observer variability was
excellent, with an agreement of 100%. According to the inho-
mogeneous and accentuated distribution of histopathologic
patterns, semiquantitative analyses were performed to describe
the predominant histologic characteristics in the entire sample.
The semiquantitative analysis was used because it is a widely
usedmethodandaccompaniedwithahighreproducibility.
25The
careful attention that was given to orientation and slice origin
(common carotid artery, bifurcation, and internal carotid artery)
of the sliced plaque by demarcation was compared with the
microPET and microCT images.
Specimens were evaluated by using a score of: I = absent
or minor staining in the entire slide; II = mild; III = moderate;
IV = extensive. In addition, regional clustered macrophages
werescoredasfollows:0 = noclusteredcells(\10%);I = few
clustered cells (10%-25%); II = small area of clustered cells
(25%-50%); III = moderate area of clustered cells (50%-75%)
IV = extensive area of clustered cells ([75% macrophages/
surface).WecomparedFDGuptakeandmacrophageinﬁltration
of endarterectomized plaques originating from asymptomatic
and symptomatic patients.
Statistical Analysis
Data were analyzed using SPSS for Windows version
16.02. Descriptive statistics are expressed as mean ± SD
(continuous variables), except time from CEA to FDG incu-
bation and FDG incubation time which are presented as
median, or as percentages to reﬂect patient details (dichoto-
mous measures). Univariate correlations were calculated using
Spearman’s rank test.
Simplelinearregressionanalysiswasperformedtoexplore
theassociationsbetweenFDGvariables(outcomevariables)and
the biomarkers calciﬁcation and CD68 (explanatory variables)
Simple linear regression analysis was also performed between
CD68 (outcome variables) and the explanatory variables bio-
markers and calciﬁcation. Linear regression analysis was
corrected for multiple segments per patients. Non-parametric
tests (Kruskal-Wallis and Mann-Whitney U) were used to
describedifferencesinsubgroupsthathadaskeweddistribution.
Values of P\.05 were considered as signiﬁcant.
RESULTS
There were clear differences between the microPET/
CT images of the CEA specimen of a representative
patient compared to a corresponding clinical PET/CT
images obtained in the same patient (Figure 1). Visually,
microPET/CT images reveal patchy FDG uptake within
the plaques. FDG microPET images of this patient
showed FDG uptake in the plaque more in detail com-
pared with the clinical PET scan.
The relation between FDG uptake and macrophage
number is plotted in Figure 2. A signiﬁcant correlation
was found between ratioFDGoverall and histological
inﬂammation [macrophage inﬁltration in the entire
slice (CD68 overall)] (r =? 0.68, P\.001; Figure 2).
Concordant with this observation, ratioFDGmax values in
the ROI were also signiﬁcantly associated with inﬂam-
mation (CD68 overall) (r =? 0.32, P\.001).
Figure 3 shows a plaque with cold and hot areas, as
deﬁned by FDG uptake, conﬁrmed by intense macro-
phage inﬁltration in the hot area and no macrophage
inﬁltration in the cold area. The calciﬁcation level
was inversely correlated with ratioFDGmax (r =- 0.84,
P\.001), meaning absent or minimal plaque calciﬁ-
cation was associated with extensive FDG uptake and
dense plaque calciﬁcation was associated with little
uptake. This inverse correlation could also be observed
for macrophages inﬂammation (mean CD68 overall) and
Figure 2. Mean maximum FDG uptake corrected for back-
ground activity (ratioFDGoverall) is signiﬁcantly correlated with
the degree of inﬂammation assessed as semi-quantitative CD
68 expression scored on the entire slide in the corresponding
plaque section (r =? 0.68, P\.001).
1070 Masteling et al Journal of Nuclear Cardiology
FDG microPET and carotid plaques November/December 2011total calcium volume within plaques (r =- 0.79,
P\.05).
Figure 4 displays the microCT image and micro-
PET image of the same plaque, for which the calciﬁed
area showed no evident FDG uptake. The mean ratio-
FDGmax was 4.08 ± 1.53 (range 1.78-8.66). In addition,
the mean of the average macrophage (CD68) clustering
score was 2.02 ± 0.95 (range 0.00-3.50).
Figure 3. FDG microPET/CT image of an ex vivo carotid plaque in the coronal plane (A),
transverse plane (B) and the corresponding histological results. An overview of the plaque with low
FDG uptake in the cranial part of the plaque and with high FDG uptake in the more caudal part of
the plaque (A). Difference in FDG uptake in a transverse section of the cranial part of the plaque
compared to the FDG uptake in a transverse section of the caudal part of the plaque (B1, B2). CD68
macrophage staining showing abundant inﬂammation (side view frame B2) in accordance with
FDG uptake values (B2). Macrophages could not be observed in the histological section that
corresponds with B1 (side view frame B1). Dapi stained nuclei are visualized (blue). The green
auto-ﬂuorescence allows an assessment of tissue structure.
Figure 4. Fused coronal FDG microPET/CT image of a heavily calciﬁed carotid plaque (A).
Coronal
18FDG microPET image (B). Blue low FDG uptake, red high FDG uptake. Coronal CT
image of the same heavily calciﬁed plaque (C).
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8.66). In addition, the mean of the average macrophage
(CD68) clustering score was 2.02 ± 0.95 (range 0.00-
3.50). There was a trend toward higher FDG uptake and
macrophage accumulation in patients displaying more
severe symptomatology, when divided into three groups
of increasing severity of symptomatology: asymptomatic
patients, patients with TIA or amaurosis fugax, and
patients with CVA, respectively (Figure 5). Figure 5
displaysratioFDGmaxvaluesandCD68stainingscoresfor
different patient symptoms. Ratio FDGmax values as well
as the degree of CD68 accumulation were signiﬁcantly
higher in CVA patients compared with TIA or amaurosis
fugaxpatients(P\.05)andCVApatientscomparedwith
asymptomatic patients (P\.05). A comparison between
patients with TIA or amaurosis fugax and asymptomatic
patients did not reach signiﬁcance.
DISCUSSION
This study demonstrates for the ﬁrst time proof of
concept to perform detailed ex vivo visualization of
carotid atherosclerotic plaques after endarterectomy
using a microPET camera system with a spatial resolu-
tion of approximately 1 mm. FDG uptake correlated
well with macrophage inﬁltration determined by immu-
nohistochemistry of CD68, an established surrogate
marker for increased local inﬂammation and decrease
plaque stability. Finally, our data also point toward a
potential link between FDG uptake and actual patient
symptoms, further stressing the usefulness of developing
PET systems with improved resolution for clinical
application.
Currently, there is a demand for novel non-invasive
screening procedures to detect potentially life-threaten-
ing vulnerable plaques.
26 FDG-PET/CT is of interest,
since FDG accumulates in activated macrophages which
are considered to be causally related to vulnerable pla-
que rupture. Moreover, in contrast to many other PET-
tracers, it is widely available. Therefore, FDG-PET/CT
represents a promising tool for better selection of
patients for CEA. However, the small differences in
ranges for TBR found between the different patient
groups, which is in accordance with the results of pre-
vious studies
12,14,20,27 reveal that it is yet not possible to
use FDG-PET/CT as a diagnostic tool. At this moment
there is, therefore, no imaging method available that has
reached the level of clinical decision-making.
Animal atherosclerotic plaque imaging studies
revealed strong correlations between FDG uptake and
macrophage content.
7,11,28 Interestingly, Davies et al.
28
demonstrated that macrophage content and ex vivo
FDG-microPET uptake correlated well in a rabbit model
(r = 0.95, P\.001), while in vivo quantiﬁcation did
not support this ﬁnding (r = 0.16, P = .57). When the
intended target is smaller than the spatial resolution,
partial volume errors (PVE) will arise. Then, surround-
ing tissue may be responsible for the observed
discrepancy. Furthermore, Tawakol et al.
11 showed in a
rabbit model that the correlation of FDG uptake and
macrophages was lower when the controls were left out
(r = 0.73 vs r = 0.93). This is of interest since there is a
need for patient selection to distinguish stable from
vulnerable plaques, instead of atherosclerotic arteries
from healthy arteries. Macrophages have a glucose
turnover at baseline which is 5- to 20-fold higher
compared to surrounding tissue. Moreover, glucose
utilization can increase 50-fold further when macro-
phages are activated.
29 Therefore, it should be feasible
to visualize macrophages containing tissue with clear
demarcation. However, atherosclerotic plaques consist
for a substantial part of necrotic tissue. Thus, more
sophisticated PET cameras need to be developed to
detect inﬁltrating macrophages using FDG and over-
come PVE. Another possibility may be the use of
technetium labeled annexin A5, an apoptosis marker that
can detect carotid plaques with a higher spatial
Figure 5. Mean maximum FDG microPET uptake corrected
for background activity (ratio FDGmax) ± SD (black bars)
and mean average concentration of clustered macrophages
(CD68) ± SD (white bars) in specimens obtained in asymp-
tomatic, TIA/amaurosis fugax and CVA patients. The graph
depicts the relation between ratioFDGmax, inﬂammation and
patient symptoms. CVA patients showed signiﬁcant increased
maximum FDG uptake and CD68 inﬁltration compared with
TIA/amaurosis fugax and asymptomatic patients (*P\.05
CVA vs asymptomatic patients, #P\.05 CVA vs TIA/
amaurosis fugax patients). There was no statistically difference
in ratioFDGmax or CD68 between asymptomatic and TIA/
amaurosis fugax patients. TIA, transient ischemic attack; CVA,
cerebrovascular accident.
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30 A plausible explanation might be that the
phosphatidyl serine (PS) binding protein annexin A5 is
far more speciﬁc than FDG which in principle accu-
mulates in all cells, and is therefore more hampered by
PVE. Annexin A5 will not only attach to PS-expressing
macrophages, but also to PS-containing blood platelets
which are abundant in plaque tissue. In contrast, FDG
might also accumulate non-speciﬁcally in surrounding
gland tissue thereby mimicking carotid plaque uptake. It
could therefore be an option to explore the properties of
more speciﬁc ligands for the assessment of the athero-
sclerotic plaque. The problem with novel tracers,
however, is their availability, which makes it more
difﬁcult to compete with FDG.
In contrast to clinical PET scanning, microPET
scanning with FDG revealed a heterogeneous accumula-
tion pattern (Figure 1), including high intensity contrasts
withintheplaquewithacleardemarcation.Thisisofgreat
clinical value since not only the presence of macrophages
but also their location in tissue are key factors in deter-
mining risk.
It has been well established that FDG accumulates
at sites of atherosclerosis in humans. However, the
correlation of in vivo FDG uptake and macrophages has
only been assessed by Graebe et al.,
27 Font et al.,
31 and
Tawakol et al.,
32 To our knowledge our study is the ﬁrst
to correlate FDG uptake in endarterectomized plaques
and macrophage content ex vivo, using microPET
scanning. The correlation we found between macro-
phages and FDG uptake was in the same range as
the correlation found by Tawakol et al.
32 (r = 0.70,
P\.001) using a clinical PET scanner. We sectioned
the plaques similar to Tawakol et al. and discovered
large differences in macrophage content between dif-
ferent section levels within a given plaque and large
differences in FDG uptake in general. However in our
study the camera resolution matched the thickness
immunohistochemistry slices well than in this previous
study. A possible explanation for this observation could
be the inclusion of surrounding tissue that interferes with
the SUV value estimation as well as the differences in
clinical camera system resolution (5-10 mm) combined
with the used section slices (3 mm).
32
Sheikine and Akram
20 suggested in a recent review
that there is a gap to bridge between FDG uptake and
histological ﬁndings. Therefore, we compared FDG
uptake and macrophage inﬁltration of endarterec-
tomized plaques originating from asymptomatic and
symptomatic patients. FDG uptake (ratioFDGmax) and
macrophage content (CD68) were not only highly cor-
related but also showed similar patterns with respect to
clinical outcome. The difference between CVA and
TIA patients reached signiﬁcance for ratioFDGmax
(P\.05). Our ﬁndings illustrate that FDG-PET may
have potential for clinical decision-making, and
underscore the clear need for more research and
sophisticated PET cameras.
The studies on FDG accumulation at sites of cal-
ciﬁcation thus far revealed conﬂicting results.
9,10,20,33-38
FDG-avid lesions and calciﬁed lesions at the same
vascular location are uncommon as mentioned in pre-
vious studies.
9,10,33-35,37 Our ﬁndings are in accordance
with these previous ﬁndings. Moreover, we also showed
that there is a high negative correlation between calci-
ﬁcation and FDG (r =- 0.84, P\.01). The excellent
spatial resolution of both microPET (*1 mm) and lCT
(37 lm) compared to the clinical PET camera system
(5-8 mm) or clinical CT (1 mm) might be an explana-
tion for the higher negative correlation as observed in
our study compared to the study of Rudd et al. (r =
-0.42, P = .03).
9 Laitinen et al.,
36 in contrast, detected
non-speciﬁc binding to calciﬁed structures using in vitro
autoradiography of FDG in calciﬁed human arteries.
They ascribed this inconsistency to the spatial resolution
of clinical CT scans compared to their ability to visu-
alize small calciﬁed structures. Use of microPET and
microCT provided an excellent visualization of small
calciﬁed structures (Figure 4). The FDG uptake seen at
the border of calciﬁcation is probably due to partial
volume effects. Therefore, it is conceivable that the
FDG uptake in calciﬁed structures noted in other studies
is an artifact of the imaging technique related to insuf-
ﬁcient resolution.
It is suggested that FDG-avid atherosclerosis is a
precursor, followed by persistent calciﬁcation at the
same site.
14,39 Paulmier et al.
40 demonstrated that
arterial calciﬁcations are closely related to old cardio-
vascular events and do not point out progressive plaque
formation, in contrast to FDG-avid lesions. Our results
thereby emphasize that plaque calciﬁcation and FDG-
avid lesions are different pathophysiologic entities.
The primary limitation of this study is that carotid
plaques are exposed to ischemia (transport and incuba-
tion time), which could potentially interfere with FDG
uptake. Despite this limitation, we observed a strong
correlation between the degree of FDG uptake and the
amount of macrophages present in the tissue. Therefore,
we assume that FDG uptake is not substantially altered
by ischemia. In addition this proof of concept study
comprises a small study population with relatively
small subgroups, in particular regarding asymptomatic
patients. However, our results still point out the clear
clinical need for PET-systems with enhanced resolution.
In conclusion, we demonstrate that carotid athero-
sclerotic plaques can be visualized ex vivo after CEA
with great detail using a high-resolution microPET
camera system revealing potentially important infor-
mation that can be easily missed with clinical PET
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Volume 18, Number 6;1066–75 FDG microPET and carotid plaquescamera systems. Interestingly, FDG uptake correlated
strongly with macrophage inﬁltration, indicating that
enhanced resolution PET imaging would be particularly
useful for the detection of vulnerable and thereby
rupture-prone plaque-areas. Our results demonstrate the
clear need for novel clinical PET/CT cameras with high
resolution for optimal vascular imaging using the readily
available FDG.
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